AIMS/ BACKGROUND: Adhesion molecules play a key role in the selective recruitment of different leucocyte population to inflammatory sites. The purpose of the present study was to investigate the presence and distribution of adhesion molecules in the conjunctiva of patients with vernal keratoconjunctivitis (VKC). METHODS: The presence and distribution of adhesion molecules were studied in 14 conjunctival biopsy specimens from seven patients with active VKC and in four normal conjunctival biopsy specimens. We used a panel of specific monoclonal antibodies (mAbs) directed against intercellular adhesion molecule-1 (ICAM-1), intercellular adhesion molecule-3 (ICAM-3), lymphocyte function associated antigen-1 (LFA-1), very late activation antigen-4 (VLA-4), vascular cell adhesion molecule-1 (VCAM-1), and endothelial leucocyte adhesion molecule-1 (ELAM-1) In addition, a panel of mAbs were used to characterise the composition of the inflammatory infiltrate. RESULTS: In the normal conjunctiva, ICAM-1 was expressed on the vascular endothelium only, LFA-1 and ICAM-3 on epithelial and stromal mononuclear cells, and VLA-4 on stromal mononuclear cells. The expression of VCAM-1 and ELAM-1 was absent. The number of cells expressing adhesion molecules was found to be markedly increased in all VKC specimens. This was concurrent with a heavy inflammatory infiltrate. Strong ICAM-1 expression was induced on the basal epithelial cells, and vascular endothelial cells. Furthermore, ICAM-I was expressed on stromal mononuclear cells. LFA-1 and ICAM-3 were expressed on the majority of epithelial and stromal infiltrating mononuclear cells. VLA-4 expression was noted on stromal mononuclear cells. Compared with controls, VKC specimens showed significantly more ICAM-3+, LFA-3+, LFA-1+, and VLA-4+ cells. VCAM-1 and ELAM-1 were induced on the vascular endothelial cells. CONCLUSIONS: Increased expression of adhesion molecules may play an important role in the pathogenesis of VKC.
AIMS/ BACKGROUND: Adhesion molecules play a key role in the selective recruitment of different leucocyte population to inflammatory sites. The purpose of the present study was to investigate the presence and distribution of adhesion molecules in the conjunctiva of patients with vernal keratoconjunctivitis (VKC). METHODS: The presence and distribution of adhesion molecules were studied in 14 conjunctival biopsy specimens from seven patients with active VKC and in four normal conjunctival biopsy specimens. We used a panel of specific monoclonal antibodies (mAbs) directed against intercellular adhesion molecule-1 (ICAM-1), intercellular adhesion molecule-3 (ICAM-3), lymphocyte function associated antigen-1 (LFA-1), very late activation antigen-4 (VLA-4), vascular cell adhesion molecule-1 (VCAM-1), and endothelial leucocyte adhesion molecule-1 (ELAM-1) In addition, a panel of mAbs were used to characterise the composition of the inflammatory infiltrate. RESULTS: In the normal conjunctiva, ICAM-1 was expressed on the vascular endothelium only, LFA-1 and ICAM-3 on epithelial and stromal mononuclear cells, and VLA-4 on stromal mononuclear cells. The expression of VCAM-1 and ELAM-1 was absent. The number of cells expressing adhesion molecules was found to be markedly increased in all VKC specimens. This was concurrent with a heavy inflammatory infiltrate. Strong ICAM-1 expression was induced on the basal epithelial cells, and vascular endothelial cells. Furthermore, ICAM-I was expressed on stromal mononuclear cells. LFA-1 and ICAM-3 were expressed on the majority of epithelial and stromal infiltrating mononuclear cells. VLA-4 expression was noted on stromal mononuclear cells. Compared with controls, VKC specimens showed significantly more ICAM-3+, LFA-3+, LFA-1+, and VLA-4+ cells. VCAM-1 and ELAM-1 were induced on the vascular endothelial cells. CONCLUSIONS: Increased expression of adhesion molecules may play an important role in the pathogenesis of VKC.
Authors: S Nakamura; H Ohtani; Y Watanabe; K Fukushima; T Matsumoto; A Kitano; K Kobayashi; H Nagura Journal: Lab Invest Date: 1993-07 Impact factor: 5.662
Authors: S Montefort; C Gratziou; D Goulding; R Polosa; D O Haskard; P H Howarth; S T Holgate; M P Carroll Journal: J Clin Invest Date: 1994-04 Impact factor: 14.808
Authors: J L Cordell; K Pulford; H Turley; M Jones; K Micklem; I A Doussis; X Tyler; K Mayne; K C Gatter; D Y Mason Journal: J Clin Pathol Date: 1994-02 Impact factor: 3.411
Authors: A M Bentley; S R Durham; D S Robinson; G Menz; C Storz; O Cromwell; A B Kay; A J Wardlaw Journal: J Allergy Clin Immunol Date: 1993-12 Impact factor: 10.793
Authors: S Montefort; I H Feather; S J Wilson; D O Haskard; T H Lee; S T Holgate; P H Howarth Journal: Am J Respir Cell Mol Biol Date: 1992-10 Impact factor: 6.914
Authors: Andrea P Martín; Julio Urrets-Zavalia; Alejandro Berra; Ana Lía Mariani; Norberto Gallino; Eduardo Gomez Demel; Julio Gagliardi; Carlos E Baena-Cagnani; Enrique Urrets-Zavalia; Horacio M Serra Journal: BMC Ophthalmol Date: 2003-01-06 Impact factor: 2.209